背景:蛋白质是生命系统中最常见的生物大分子,是生命的组成部分。它们在结构和功能上非常动态。由于多次修改,蛋白质发生错误折叠,导致聚集,从而发展为神经退行性疾病和全身性疾病。因此,了解这些疾病的病理学以及用于诊断它们的技术对于它们的有效管理至关重要。有几种技术,目前正在使用诊断它们,这些将在这篇综述中讨论。
目的:本综述旨在概述蛋白质聚集以及与神经变性和全身性疾病相关的潜在机制。此外,这篇评论强调了蛋白质错误折叠障碍,他们的临床诊断,和治疗策略。
方法:通过PubMed探索与神经退行性疾病和全身性疾病有关的文献,谷歌学者,Scopus,和Medline数据库。用于文献调查和分析的关键词是蛋白质聚集,神经退行性疾病,老年痴呆症,帕金森病,全身性疾病,蛋白质聚集机制,等。讨论/结论:这篇综述总结了由蛋白质错误折叠和聚集引起的神经退行性疾病和全身性疾病的发病机制。还讨论了用于管理这些疾病的临床诊断和治疗策略,以帮助更好地了解蛋白质错误折叠疾病。关于这个角色的许多重大担忧,特点,以及蛋白质聚集体在神经退行性疾病和全身性疾病中的后果迄今尚不清楚。不管技术的进步,这些疾病的管理和治疗仍然存在很大困难。因此,为了更好地理解,诊断,神经退行性疾病和全身性疾病的治疗,需要更多的研究来确定可能有助于治疗和管理的新药。
Proteins are the most common biological macromolecules in living system and are building blocks of life. They are extremely dynamic in structure and functions. Due to several modifications, proteins undergo misfolding, leading to aggregation and thereby developing neurodegenerative and systemic diseases. Understanding the pathology of these diseases and the techniques used to diagnose them is therefore crucial for their effective management . There are several techniques, currently being in use to diagnose them and those will be discussed in this
review.
Current
review aims to discuss an overview of protein aggregation and the underlying mechanisms linked to neurodegeneration and systemic diseases. Also, the
review highlights protein misfolding disorders, their clinical diagnosis, and treatment strategies.
Literature related to neurodegenerative and systemic diseases was explored through PubMed, Google Scholar, Scopus, and Medline databases. The keywords used for literature survey and analysis are protein aggregation, neurodegenerative disorders, Alzheimer\'s disease, Parkinson\'s disease, systemic diseases, protein aggregation mechanisms, etc. DISCUSSION /CONCLUSION: This
review summarises the pathogenesis of neurodegenerative and systemic disorders caused by protein misfolding and aggregation. The clinical diagnosis and therapeutic strategies adopted for the management of these diseases are also discussed to aid in a better understanding of protein misfolding disorders. Many significant concerns about the role, characteristics, and consequences of protein aggregates in neurodegenerative and systemic diseases are not clearly understood to date. Regardless of technological advancements, there are still great difficulties in the management and cure of these diseases. Therefore, for better understanding, diagnosis, and treatment of neurodegenerative and systemic diseases, more studies to identify novel drugs that may aid in their treatment and management are required.